Caplin Point Laboratories Limited develops, produces, markets, and exports generic pharmaceutical formulations and branded products in India. The company provides liquid and lyophilized injections, ophthalmic products, tablets, liquid orals, capsules, softgel capsules, suppositories and ovules, powder for injection, dry syrups, topicals, inhalers, IV infusions, lyophilized products, branded products, dermo cosmetics, and other products. It also operates QueTenX, an e-commerce website. The company was incorporated in 1990 and is headquartered in Chennai, India.

NSE:CAPLIPOINT

Caplin Point Laboratories Limited

Last Close

1,363.80

17/05 10:00

Market Cap

107.86B

Beta: 0.37

Volume Today

135.01K

Avg: 105.40K

PE Ratio

25.48

PFCF: 2,052.18

Dividend Yield

0.32%

Payout:0%

Financials Not Available